Showing results (1-10 of 188) with videos related to
Sort By:
Pageof 19
Methods in Enzymology|January 13, 2004
Influenza virosomes in vaccine developmentAnke Huckriede, Laura Bungener, Toos Daemen, et al.Bioscience Reports|November 14, 2002
Delivery of protein antigens to the immune system by fusion-active virosomes: a comparison with liposomes and ISCOMsLaura Bungener, Anke Huckriede, Jan Wilschut, et al.Journal of Liposome Research|February 27, 2003
Virosomes in vaccine development: induction of cytotoxic T lymphocyte activity with virosome-encapsulated protein antigensLaura Bungener, Jacqueline Idema, Wouter ter Veer, et al.Advanced Drug Delivery Reviews|November 25, 2004
Virosomes for antigen and DNA deliveryToos Daemen, Arjan de Mare, Laura Bungener, et al.Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|February 2, 2006
Recombinant alphaviruses as vectors for anti-tumour and anti-microbial immunotherapyAnnelies Riezebos-Brilman, Arjan de Mare, Laura Bungener, et al.Vaccine|July 20, 2005
The virosome concept for influenza vaccinesAnke Huckriede, Laura Bungener, Toon Stegmann, et al.Vaccine|January 18, 2005
Virosome-mediated delivery of protein antigens in vivo: efficient induction of class I MHC-restricted cytotoxic T lymphocyte activityLaura Bungener, Anke Huckriede, Arjan de Mare, et al.Vaccine|March 9, 2004
Induction of cytotoxic T lymphocyte activity by immunization with recombinant Semliki Forest virus: indications for cross-primingAnke Huckriede, Laura Bungener, Marijke Holtrop, et al.Vaccine|February 1, 2003
Eradication of established HPV16-transformed tumours after immunisation with recombinant Semliki Forest virus expressing a fusion protein of E6 and E7Toos Daemen, Annelies Riezebos-Brilman, Laura Bungener, et al.Vaccine|May 16, 2002
Virosome-mediated delivery of protein antigens to dendritic cellsLaura Bungener, Karine Serre, Liesbeth Bijl, et al.Pageof 19